Plain-English translation of NCT04880200 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a point-of-care nucleic acid test (POC NAT)—a faster HIV blood test that gives results during your visit instead of waiting for lab results. The study wants to see if this faster test helps people living with HIV start treatment sooner and stay on their medication, and whether it encourages people at risk to use prevention tools like PrEP.
Many people with HIV don't get diagnosed quickly enough or don't start treatment right away, which delays their health improvement. This trial is testing whether a faster, on-the-spot blood test can help people get diagnosed and into care more quickly, and whether it helps people stay committed to their treatment and prevention plans.
You likely qualify if…
You likely don't qualify if…
If you are in the treatment group, you will have the faster blood test done during your regular clinic visit, and your provider will share the results with you and discuss ways to help you stay on track with your medication. If you are in the standard care group, you will receive your usual clinic visit and testing. Both groups will help researchers understand whether the faster test improves how quickly people get the care they need.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
United States
University of Washington
Collaborators
Centers for Disease Control and Prevention
Enrollment target
~932 participants
Started
January 2022
Primary completion
August 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lisa Niemann
University of Washington
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.